GSK (GSK): news on Friday 2 October 2026

The 12 stories

Each headline's own score, strongest first. Links go to the publisher.

• +7.5 NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company? stocktwits.com
  Reported acquisition of oncology company Nuvalent, expanding cancer pipeline.
• +6.7 GSK adds liver candidate from Wave RNA partnership European Biotechnology Magazine
  GSK adds liver candidate from Wave partnership.
• −6.7 Why is GSK stock down today? Selloff intensifies, key levels to watch Traders Union
  Selloff in GSK shares intensifies.
• +6.0 Wave lands USD 12m as GSK advances SpiNA siRNA program AllSci
  GSK advances siRNA programme, triggering milestone payment to Wave.
• −5.8 GSK plc : JP Morgan reiterates its Sell rating marketscreener.com
  JP Morgan maintains Sell rating.
• +5.5 How Is GSK (LSE:GSK) Stock Reacting This Week To Its Wave Life Sciences Liver Candidate? Kalkine Media
  Wave liver candidate progress and share reaction.
• −4.2 What's behind GSK's latest 1.8% stock pullback? Traders Union
  Share price pullback of 1.8%.
• +3.7 Why Did Haleon (LSE:HLN) Draw Attention As GSK Completed Its Exit This Week? Kalkine Media
  GSK completed its exit from Haleon stake.
• +3.0 Kristian Jensen: Begining a New Chapter at GSK After Novartis Journey oncodaily.com
  Senior hire from Novartis joining GSK.
• −2.5 GSK stock after-hours at EUR 21.03: minus 1.36 percent versus prior close AD HOC NEWS
  Shares slipped modestly after hours.
• +0.8 Tyler Reynolds Joins GSK as Director, Digital Medicine BioBuzz
  Minor digital medicine hire.
• 0.0 The Technical Signals Behind (GSK) That Institutions Follow Stock Traders Daily
  Generic technical analysis commentary on the shares, no new information.